Jackie Soo1, Mayris P Webber2, Charles B Hall3, Hillel W Cohen3, Theresa M Schwartz1, Kerry J Kelly4, David J Prezant1. 1. Department of Medicine, Montefiore Medical Center, Bronx, NY; Bureau of Health Services, Fire Department of the City of New York, Brooklyn, NY. 2. Department of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY; Bureau of Health Services, Fire Department of the City of New York, Brooklyn, NY. Electronic address: webberm@fdny.nyc.gov. 3. Department of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY. 4. Bureau of Health Services, Fire Department of the City of New York, Brooklyn, NY.
Abstract
BACKGROUND: We examined the relationship between pulmonary function (FEV 1 ) and confirmed recovery from three lower-respiratory symptoms (LRSs) (cough, dyspnea, and wheeze) up to 9 years after symptom onset. METHODS: The study included white and black male World Trade Center (WTC)-exposed firefighters who reported at least one LRS on a medical monitoring examination during the fi rst year after September 11, 2001. Confirmed recovery was defined as reporting no LRSs on two consecutive and all subsequent examinations. FEV 1 was assessed at the fi rst post-September 11, 2001, examination and at each examination where symptom information was ascertained. We used stratified Cox regression models to analyze FEV 1 , WTC exposure, and other variables in relation to confirmed symptom recovery. RESULTS: A total of 4,368 fi refighters met inclusion criteria and were symptomatic at year 1, of whom1,592 (36.4%) experienced confirmed recovery. In univariable models, fi rst post-September 11,2001, concurrent, and difference between fi rst post-September 11, 2001, and concurrent FEV 1 values were all significantly associated with confirmed recovery. In adjusted analyses, both fi rst post-September 11, 2001, FEV 1 (hazard ratio [HR], 1.07 per 355-mL difference; 95% CI, 1.04-1.10) and FEV 1 % predicted (HR, 1.08 per 10% predicted difference; 95% CI, 1.04-1.12) predicted confirmed recovery. WTC exposure had an inverse association with confirmed recovery in the model with FEV 1 , with the earliest arrival group less likely to recover than the latest arrival group (HR, 0.73;95% CI, 0.58-0.92). CONCLUSIONS: Higher FEV 1 and improvement in FEV 1 after September 11, 2001, predicted confirmed LRS recovery, supporting a physiologic basis for recovery and highlighting consideration of spirometry as part of any postexposure respiratory health assessment.
BACKGROUND: We examined the relationship between pulmonary function (FEV 1 ) and confirmed recovery from three lower-respiratory symptoms (LRSs) (cough, dyspnea, and wheeze) up to 9 years after symptom onset. METHODS: The study included white and black male World Trade Center (WTC)-exposed firefighters who reported at least one LRS on a medical monitoring examination during the fi rst year after September 11, 2001. Confirmed recovery was defined as reporting no LRSs on two consecutive and all subsequent examinations. FEV 1 was assessed at the fi rst post-September 11, 2001, examination and at each examination where symptom information was ascertained. We used stratified Cox regression models to analyze FEV 1 , WTC exposure, and other variables in relation to confirmed symptom recovery. RESULTS: A total of 4,368 fi refighters met inclusion criteria and were symptomatic at year 1, of whom1,592 (36.4%) experienced confirmed recovery. In univariable models, fi rst post-September 11,2001, concurrent, and difference between fi rst post-September 11, 2001, and concurrent FEV 1 values were all significantly associated with confirmed recovery. In adjusted analyses, both fi rst post-September 11, 2001, FEV 1 (hazard ratio [HR], 1.07 per 355-mL difference; 95% CI, 1.04-1.10) and FEV 1 % predicted (HR, 1.08 per 10% predicted difference; 95% CI, 1.04-1.12) predicted confirmed recovery. WTC exposure had an inverse association with confirmed recovery in the model with FEV 1 , with the earliest arrival group less likely to recover than the latest arrival group (HR, 0.73;95% CI, 0.58-0.92). CONCLUSIONS: Higher FEV 1 and improvement in FEV 1 after September 11, 2001, predicted confirmed LRS recovery, supporting a physiologic basis for recovery and highlighting consideration of spirometry as part of any postexposure respiratory health assessment.
Authors: Gisela I Banauch; Dawn Alleyne; Raoul Sanchez; Kattia Olender; Hillel W Cohen; Michael Weiden; Kerry J Kelly; David J Prezant Journal: Am J Respir Crit Care Med Date: 2003-02-25 Impact factor: 21.405
Authors: David J Prezant; Michael Weiden; Gisela I Banauch; Georgeann McGuinness; William N Rom; Thomas K Aldrich; Kerry J Kelly Journal: N Engl J Med Date: 2002-09-09 Impact factor: 91.245
Authors: Iris Udasin; Clyde Schechter; Laura Crowley; Anays Sotolongo; Michael Gochfeld; Benjamin Luft; Jacqueline Moline; Denise Harrison; Paul Enright Journal: J Occup Environ Med Date: 2011-01 Impact factor: 2.162
Authors: Stephen M Friedman; Carey B Maslow; Joan Reibman; Parul S Pillai; Roberta M Goldring; Mark R Farfel; Steven D Stellman; Kenneth I Berger Journal: Am J Respir Crit Care Med Date: 2011-09-01 Impact factor: 21.405
Authors: Daniela Nuvolone; Roberto Della Maggiore; Sara Maio; Roberto Fresco; Sandra Baldacci; Laura Carrozzi; Francesco Pistelli; Giovanni Viegi Journal: Environ Health Date: 2011-03-01 Impact factor: 5.984
Authors: Joan Reibman; Nomi Levy-Carrick; Terry Miles; Kimberly Flynn; Catherine Hughes; Michael Crane; Roberto G Lucchini Journal: Ann Am Thorac Soc Date: 2016-05
Authors: Michael D Weiden; Sophia Kwon; Erin Caraher; Kenneth I Berger; Joan Reibman; William N Rom; David J Prezant; Anna Nolan Journal: Semin Respir Crit Care Med Date: 2015-05-29 Impact factor: 3.119
Authors: Michelle S Glaser; Mayris P Webber; Rachel Zeig-Owens; Jessica Weakley; Xiaoxue Liu; Fen Ye; Hillel W Cohen; Thomas K Aldrich; Kerry J Kelly; Anna Nolan; Michael D Weiden; David J Prezant; Charles B Hall Journal: Am J Epidemiol Date: 2014-06-30 Impact factor: 4.897
Authors: Kathleen A Clark; Debjani Chanda; Pallavi Balte; Wilfried J Karmaus; Bo Cai; John Vena; Andrew B Lawson; Lawrence C Mohr; James J Gibson; Erik R Svendsen Journal: BMC Public Health Date: 2013-10-09 Impact factor: 3.295
Authors: David G Goldfarb; Barbara Putman; Lies Lahousse; Rachel Zeig-Owens; Brandon M Vaeth; Theresa Schwartz; Charles B Hall; David J Prezant; Michael D Weiden Journal: Am J Ind Med Date: 2021-07-13 Impact factor: 3.079